Skip to main content
Premium Trial:

Request an Annual Quote

Reaction Biology Receives $940,000 SBIR Grant From NCI to Develop Microarray-Based HTS Method

NEW YORK, June 19 (GenomeWeb News) - Reaction Biology has received a $940,000 Small Business Innovation Research grant from the National Cancer Institute to create a new kinase profiling and high-throughput screening method using radioisotopes and microarrays, the company announced today.


Reaction Biology said the it will use the funding to move current well-plate radioisotope methods onto its DiscoveryDot nanoliter screening platform.


The nanoliter platform uses much less radioisotope compared to well-plate methods, which "should lead to far fewer disposal and handling problems, and reduced cost overall," Reaction Biology's chief technology officer, Haiching Ma, said in a statement.


In March, the company was awarded a $1.8 million grant from the National Human Genome Research Institute to develop the DiscoveryDot platform under the Molecular Libraries and Imaging Initiative of the NIH Roadmap.